Ukr.Biochem.J. 2020; Volume 92, Issue 2, Mar-Apr, pp. 33-43

doi: https://doi.org/10.15407/ubj92.02.033

Lectinocytochemical study of rat stomach mucosa under the conditions of cyclooxygenase-1/-2 blockage and pretreatment witH H-Glu-Asp-Gly-OH

C. M. Nasadyuk1*, E. A. Sogomonyan2, A. M. Yashchenko2, A. Y. Sklyarov1

1Department of Biochemistry, Danylo Halytsky Lviv National Medical University, Ukraine;
2Department of Histology, Danylo Halytsky Lviv National Medical University, Ukraine;
*e-mail: nasadyukch@gmail.com

Received: 22 December 2019; Accepted: 27 March 2020

Assessment of glycoconjugate expression on cell membranes using the lectin histochemistry technique may be a feasible approach for evaluating the functional state of the cell. The aim of this study was to evaluate carbohydrate determinants of rat stomach mucosa cell membranes under the conditions of COX-1/-2 blockage­ with indomethacin and pretreatment with the tripeptide H-Glu-Asp-Gly-OH. Male Wistar rats were divided into 3 groups (n = 6 per group): 1st group (control) received vehicle; 2nd – indomethacin (35 mg/kg); 3rd – H-Glu-Asp-Gly-OH (10 µg) 30 min before indomethacin. Rats were sacrificed 24 hours later. Gastric mucosa (GM) carbohydrate determinants were studied by lectin-peroxidase technique. The lectins panel included α-fucose- (LABA), syalo- (WGA, SNA), mannose- (Con A, LCA) and galactose-specific (HPA, PNA, SBA) lectins. Intensity of lectin-receptor reaction was scored: 0 – no reaction; 1 – weak; 2 – mild; and 3 – strong reaction. COX-1/2 blockage caused GM lesions, attenuated by H-Glu-Asp-Gly-OH. WGA and SNA showed the highest affinity to GM. Indomethacin decreased SNA-labeling of epitheliocytes and mucocytes and LABA-labeling of chief cells. H-Glu-Asp-Gly-OH reversed the glycosylation changes, caused by COX-1/COX-2 blockage only in regards to labeling of chief cells with LABA, epitheliocytes and mucocytes with LCA, mucocytes with SNA. Predominantly H-Glu-Asp-Gly-OH under COX-1/COX-2 blockage had an effect opposite to indomethacin alone but glycosylation changes under these conditions differed significantly also from the control. COX-1/COX-2 blockage causes alteration of glycosylation processes in rat GM, mainly reduction of NeuNAc(α2-6)DGal and α-Fuc content. H-Glu-Asp-Gly-OH under the conditions of COX-1/COX-2 blockage leads to more profound changes in GM lectin-binding pattern compared to the independent effect of indomethacin and to control.

Keywords: , , , , , ,


References:

  1. Fomenko I, Sklyarov A, Bondarchuk T, Biletska L, Panasyuk N, Wallace JL. Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage. Stress. 2014; 17(6): 528-537. PubMed, CrossRef
  2. Nasadyuk C, Sklyarov A. Thymohexin exhibits cytoprotective effect in experimental gastric lesions in rats both through the inhibition of inducible nitric oxide synthase and reduction of oxidative mucosal damage. Regul Pept. 2013; 180: 50-57. PubMed, CrossRef
  3. Nasadyuk CM, Sklyarov AY. The first report on the gastroprotective effect of tripeptide T-34 under conditions of water-immobilisation stress in rats. United Eur Gastroenterol J. 2014; 2 (1 Suppl): A255.
  4. Nasadyuk C, Sklyarov A. Gastroprotective oligopeptides. Gastroenterol Hepatol. Open Access. 2015;3(1): 00068.  CrossRef
  5. Drmic D, Kolenc D, Ilic S, Bauk L, Sever M, Sever AZ, Luetic K, Suran J, Seiwerth S, Sikiric P. Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME. World J Gastroenterol. 2017; 7; 23(29): 5304-5312. PubMed, PubMedCentral, CrossRef
  6. Gyires K, Toth VE, Zadori ZS. Gastric mucosal protection: from the periphery to the central nervous system. J Physiol Pharmacol. 2015; 66(3): 319-329. PubMed
  7. Shimokawa T, Doihara T, Makara M, Miyawaki K, Nabeka H, Wakisaka H, Kobayashi N, Matsuda S. Lectin binding pattern of gastric mucosa of Pacific White-Sided Dolphin, Lagenorhynchus obliquidens. J Vet Med Sci. 2012; 74(2): 155-160. PubMed, CrossRef
  8. Zhao YP, Xu XY, Fang M, Wang H, You Q, Yi CH, Ji J, Gu X, Zhou PT, Cheng C, Gao CF. Decreased core-fucosylation contributes to malignancy in gastric cancer. PLoS One. 2014; 9(4): e94536.
    PubMed, PubMedCentral, CrossRef
  9. Huang W-L, Li Y-G, Lv Y-C, Guan X-H, Ji H-F, Chi B-R. Use of lectin microarray to differentiate gastric cancer from gastric ulcer. World J Gastroenterol. 2014; 20(18): 5474-5482. PubMed, PubMedCentral, CrossRef
  10. Yashchenko AM, Lutsyk SA, Renka DJ, Bilyy RO, Lutsyk DA. Alterations in carbohydrate determinants in rat adrenal gland following experimental hypothyroidism. Eur J Anat. 2014; 18 (2): 75-80.
  11. Khavinson VKh, Lin’kova NS, Dudkov AV, Polyakova VO, Kvetnoi IM. Peptidergic regulation of expression of genes encoding antioxidant and anti-inflammatory proteins. Bull Exp Biol Med. 2012; 152(5): 615-618. (In Russian). PubMed, CrossRef
  12. Akimoto Y, Takata K, Kawakami H. Pre-embedding method of electron microscopy for glycan localization in mammalian tissues and cells using lectin probes.  Methods Mol Biol. 2016; 1474: 259-267. PubMed, CrossRef
  13. Gao N, Bergstrom K, Fu J, Xie B, Chen W, Xia L. Loss of intestinal O-glycans promotes spontaneous duodenal tumors. Am J Physiol Gastrointest Liver Physiol. 2016; 311(1): G74-83. PubMed, PubMedCentral, CrossRef
  14. Almeida A, Kolarich D. The promise of protein glycosylation for personalised medicine. Biochim Biophys Acta. 2016; 1860(8): 1583-1595. PubMed, CrossRef
  15. Oommen AM, Somaiya N, Vijayan J, Kumar S, Venkatachalam S, Joshi L. GlycoGAIT: A web database to browse glycogenes and lectins under gastric inflammatory diseases.  J Theor Biol. 2016; 406: 93-98. PubMed, CrossRef
  16. Kavanaugh D, O’Callaghan J, Kilcoyne M, Kane M, Joshi L, Hickey RM. The intestinal glycome and its modulation by diet and nutrition. Nutr Rev. 2015; 73(6): 359-375. PubMed, CrossRef
  17. Caputi S, Trubiani O, Sinjari B, Trofimova S, Diomede F, Linkova N, Diatlova A, Khavinson V. Effect of short peptides on neuronal differentiation of stem cells. Int J Immunopathol Pharmacol. 2019; 33: 2058738419828613. PubMed, PubMedCentral, CrossRef
  18. Falalyeyeva TM, Beregova TV, Samonina GE, Yashchenko AM. Carbohydrate components of the glycoprotein receptors of gastric mucosa after prophylactic medication with glyprolines in rats under stress-induced lesions. World Med Biol. 2011;(2(29)):67-71. (In Ukrainian).
  19. Yamamoto K, Qi WM, Yokoo Y, Miyata H, Udayanga KG, Kawano J, Yokoyama T, Hoshi N, Kitagawa H. Lectin histochemical detection of special sugars on the mucosal surfaces of the rat alimentary tract. J Vet Med Sci. 2010; 72(9): 1119-1127. PubMed, CrossRef
  20. Roy B, Chattopadhyay G, Mishra D, Das T, Chakraborty S, Maiti TK. On-chip lectin microarray for glycoprofiling of different gastritis types and gastric cancer. Biomicrofluidics. 2014; 8(3): 034107. PubMed, PubMedCentral, CrossRef
  21. Magazina MA, Bagaeva TR, Filaretova LP. Metyrapone effect on gastroprotective action of corticotropin-releasing factor administered centrally against indomethacin-induced gastric injury. Ross Fiziol Zh Im Sechenova. 2014; 100(12): 1421-1430. (In Russian). PubMed
  22. Gomez-Santos L, Alonso E, Diaz-Flores L, Madrid JF, Saez FJ. Different glycoconjugate content in mucus secreting cells of the rat fundic gastric glands. Anat Rec. 2018; 301(12): 2128-2144. PubMed, CrossRef
  23. Li X, Guan F, Li D, Tan Z, Yang G, Wu Y, Huang Z. Identification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses. Oncotarget. 2016; 7 (52): 87284-87300. PubMed, PubMedCentral, CrossRef
  24. Donczo B, Kerekgyarto J, Szumai Z, Guttman A. Glycan microarrays: new angles and new strategies.
    Analyst. 2014; 139 (1): 2650-2657. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.